INTRODUCTION
Chronic cough and phlegm production are common respiratory symptoms. In the past, these were often considered together as the clinical phenotype of chronic bronchitis, 1 but more recently phlegm 2 and cough 3 have been considered separately and may have differing mechanisms-for example, cough may result from central reflex sensitivity 4 as well as irritation and inflammation. A previous study of young adults found wide geographic variability in
Key messages
What is the key question?
▸ Is long-term exposure to traffic or ambient air pollution associated with prevalence of cough and phlegm in adult European populations?
What is the bottom line?
▸ Current long-term average air pollution levels were not associated with symptoms of chronic bronchitis, cough or phlegm in European adults of all ages living in nine European countries, but there were small increases in reported phlegm in never-smokers associated with coarse particulate matter.
Why read on?
▸ This is one of the largest such studies in adults involving >10 000 individuals in five European cohorts using harmonised exposure and outcome measurements; while most results were null, there was some heterogeneity across findings for cohort assessments at different time points, particularly for black carbon and NO 2 .
chronic bronchitis prevalence (0.7-9.7%) across Europe, but only 30% of the variability could be explained by differences in smoking habits. 5 This suggests other potentially modifiable factors-such as air pollution-may be important.
There is good evidence that air pollution triggers exacerbations in patients with COPD, and suggestive evidence of chronic effects of air pollution on the prevalence and incidence of COPD in adults. 6 Concurrent asthma may give rise to cough and phlegm. Traffic-related air pollution has also been related to onset of childhood asthma, but findings in adults are less clear. 7 Pathophysiological studies have found associations between long-term exposure to ambient particulate matter (PM) and chronic mucosal inflammation in the lung, 8 resulting in excessive mucus secretion, coughing and phlegm production. 9 Previous epidemiological studies examining associations between objectively measured air pollution and chronic bronchitis symptoms in adults [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] are difficult to compare. For example, some studies have used surrogate measures for air pollution (eg, distance from the main road, 13 20 21 27 traffic intensity 17 ), others used air pollution data from local monitoring networks 10-13 16 22 23 25 26 or model-derived exposures estimated at home address. 15 17 19 24 Some 13 15 17 but not all 14 18 19 23 studies reported increased risks in the general population, whereas studies in specific populations reported associations only in never-smokers 10-12 16 26 or females. 20 21 25 The present study investigates cross-sectional associations between ambient air pollution estimated at home address and prevalence of chronic bronchitis symptoms in five European cohort studies participating in European Study of Cohorts for Air Pollution Effects (ESCAPE) project. Taking advantage of individual information and repeated assessments, we gave special attention to the time period of exposure (contemporary, historic 2000s and historic 1990s exposures) in repeated crosssectional analyses and conducted extensive sensitivity analyses.
METHODS

Study populations
Analyses were based on subpopulations from the European Community Respiratory Health Survey (ECRHS); National Survey of Health and Development (NSHD) from the UK; the Study on the influence of Air pollution on Lung function, Inflammation and Aging (SALIA) from Ruhr area in Germany; the Swiss cohort study on Air Pollution And Lung and heart Diseases in Adults (SAPALDIA); and the French Asthma-E3N study, an asthma case-control study nested in the 'Etude Épidémiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N)' cohort who were living in geographic areas covered by ESCAPE exposure models ('ESCAPE areas'). A brief description of each cohort is available in online supplements-1. Those included in the analyses had valid chronic bronchitis data and information on sex, age, smoking status, season of questionnaire interview, education. The NSHD, SALIA and SAPALDIA contributed information from two assessment rounds. Ethical approvals for analyses were obtained for all cohorts.
Outcome definition
Chronic bronchitis symptoms were assessed by questionnaire in all cohorts using standard questions based on those defined by the British Medical Research Council (MRC) in 1965, 1 as reported cough and phlegm production first thing in the morning and/or during the day or at night for 3 months of the year for ≥2 years. Other outcomes investigated were chronic cough (reported cough for 3 months for ≥2 years regardless of reported phlegm or not) and chronic phlegm (reported phlegm for 3 months for ≥2 years regardless of reported cough or not), except for SALIA, where questions regarding phlegm production were not asked separately from cough, therefore it was not possible to derive the outcome of 'chronic phlegm' (online supplements-2).
Exposure measurements ESCAPE-period exposures
The ESCAPE exposure assessments have been described elsewhere. 28 29 Briefly, a standardised protocol was applied in all geographic sites within the ESCAPE areas during October 2008 to April 2011. Nitrogen dioxide (NO 2 ) and nitrogen oxides (NO x ) measurements were conducted in 36 ESCAPE study areas while PM (PM 10 , PM with aerodynamic diameter ≤10 mm and PM 2.5 , PM with aerodynamic diameter ≤2.5 mm) were measured in 20 ESCAPE study areas, both in a 14-day period of each of three seasons (cold, warm and intermediate). Annual average concentrations for each monitoring site were calculated by combining the three 14-day periods with measurement data from a centrally located reference site, in operation during the whole study period, to adjust for temporal variability. The land-use regression (LUR) model developed used geographic information system (GIS)-derived predictor variables to describe spatial variation of annual average concentrations for each study area at measurement locations. An annual average estimate was then assigned from the LUR models to each geocoded address (place of residence) based on the date of questionnaire assessment for study participants. In addition, two indicators of local exposures to traffic were derived for each participant's address: traffic intensity on the nearest road (traffic intensity, vehicles/ day) and total traffic load on major roads in a 100 m buffer (traffic load, vehicles*m/day).
Each participant was assigned an annual average concentration at home outdoor of NO 2 , NO x and the background levels of NO 2 . For participants residing within ESCAPE areas with PM measurements, they were also assigned exposures to PM 2.5 , PM 10 , the coarse fraction of PM (PM coarse as PM 10 minus PM 2.5 ) and PM 2.5abs , the light absorbance of PM 2.5 (similar to 'black carbon').
Back-extrapolation
Questionnaire assessments in some cohorts occurred prior to the ESCAPE monitoring campaign in 2008-2011, with some up to 25 years earlier. Due to changes (usually decreases) in air pollution over time, ESCAPE-period exposure values were backextrapolated to the years of collection of health data assuming proportional changes in within-city spatial patterns. Here, individually assigned estimates of ambient concentrations were adjusted (calibrated) for the long-term trends using a predefined backextrapolation algorithm (see http://www.escapeproject.eu/manuals/ Procedure_for_extrapolation_back_in_time.pdf; accessed 10 May 2014).
Back-extrapolation for NO 2 and PM 10 was conducted by ratio methods to the most recent follow-up years in ECRHS and SAPALDIA (assessments in 1998-2002 and 2002, respectively) and also to earlier assessment in SALIA in 1985-1994, NSHD in 1999 and SAPALDIA in 1991.
Statistical analyses
Each cohort was first analysed separately using centrally written analytic codes, and harmonised outcome and confounder variables. Descriptive analyses were conducted including Spearman correlation coefficients. The analytic strategy, including all models, sensitivity and subgroup analyses, was specified a priori, based on current knowledge. Cross-sectional analyses using logistic regression models were undertaken to obtain cohortspecific ORs. Results were then combined using both fixed effects and random effects meta-analyses; pooled estimates from the latter were only shown when heterogeneity ( p<0.05) existed across cohorts.
The main analyses used 'ESCAPE-period exposure' for 2008-2011 applied to the most recent assessment within 10 years of exposure models in all five cohorts (earliest ECRHS and SAPALDIA with assessments in 2002).
A sequence of nested models were run for each outcome: model 1-unadjusted crude model; model 2-adjustments of age and sex; model 3 (main model)-further adjusted for smoking, education level and interview season, all uniformly defined in all cohorts. Model 4 was further adjusted for environmental tobacco smoking (ETS) exposures at home and/or at work and occupational exposures to any of vapours/gases/dusts/ fumes (VGDF); availability and definition of these differed across cohorts. Model 5 was a study-specific model further adjusted for smoking pack years and locally defined neighbourhood-level socioeconomic status. All traffic indicator models were adjusted for the background NO 2 (NO 2 not directly influenced by traffic) to better estimate near traffic effects.
In main analyses, based on model 3 using ESCAPE-period exposures, cohort-specific sensitivity analyses were conducted (i) on the following potentially sensitive subgroups: females, asthmatics, those aged ≥50 years and never-smokers; (ii) excluding those with COPD and/or asthma.
All cohort-specific results from model 3 (or where appropriate, related subgroup and/or sensitivity analyses), were then combined using both fixed effects and random effect meta-analyses by the Stata metan command; pooled estimates from the latter were only shown when heterogeneity ( p<0.05) existed across cohorts. Results presented/used in the meta-analyses for multicountry study ECRHS were from random effect models with city modelled as a random effect while the other four were from fixed effect models with country/area modelled as a fixed effect.
Further sensitivity analyses were conducted to address issues relating to cohort heterogeneity and exposure estimation. In main analyses, based on model 3 using ESCAPE-period exposures, cohort heterogeneity was investigated in leave-one-out meta-analyses, where each cohort was dropped in turn. To investigate exposure issues, we (i) conducted meta-analyses excluding centres with poorer exposure model validation statistics (R 2 <0.6); (ii) restricted analyses to non-movers (those who did not move between the most recent and previous assessment, which were at least 8 years apart); (iii) conducted analyses using 'contemporary exposure estimates'; these used ESCAPE 2008-2011 estimates for Asthma-E3N (2011), NSHD (2008) and SALIA (2006/2010) , that is, excluding SAPALDIA and ECHRHS where questionnaire assessments were >6 years prior to exposure estimation; (iv) conducted analyses using 'historic exposure estimates' back-extrapolated to year of assessment for assessments in -2002 (ECRHS 2002 , NSHD 1999 , SAPALDIA 2002 ) and in the early 1990s (SAPALDIA 1991 , SALIA 1985 -1994 , that is, when exposures were higher.
Statistical analyses were performed using Stata V.12.0, Texas, USA. Statistical significance was set at p value <0.05.
RESULTS
For main analyses using ESCAPE-period estimates for the most recent assessment, there were 15 279 participants successfully assigned at least NO 2 estimates (table 1) and 10 537 participants assigned at least PM 10 estimates (see online supplements-3) with information on variables of main model 3. At the most recent assessment, mean age of the study population ranged from 42.9 years (ECRHS) to 71.5 years (SALIA). Asthma-E3N and SALIA were cohorts of older females only. Current smokers ranged from 5.3% (SALIA) to 32% in the younger general population of ECRHS. Asthma-E3N participants were mainly teachers, and 91.3% were highly educated compared with 11.5% in NSHD. VGDF exposure was 30-40% in the mixed sex general population cohorts (ECRHS, NSHD, SAPALDIA) but lower in the female cohorts. Prevalence of chronic bronchitis ranged from 1.5% (Asthma-E3N) to 6.8% (SALIA) (see online supplements-4).
Summary statistics of ESCAPE-period air pollutants and traffic indicators are presented in online supplements-5. Mean NO 2 ranged from 22 mg/m 10 . Exposures back-extrapolated to the 1990s were higher than for estimates at later assessments.
Spearman correlation coefficients between PM and NO x /NO 2 metrics were high (r∼0.7-0.8), therefore precluding two pollutant analyses, while correlations between pollutants and traffic measures were low to moderate (r∼0.3-0.5) (see online supplements-6).
ESCAPE-period exposure estimates 2008-2011 were highly correlated (r>0.9) with exposures back-extrapolated to the assessments in 2002 ECRHS and SAPALDIA, justifying the use of ESCAPE-period exposures in main analyses.
Results from analyses using ESCAPE-period exposure estimates
Combined estimates from the meta-analyses using model 3 are displayed in table 2 (see also figure 1 and Forest plots, online supplements-7). No statistically significant overall associations were found between any air pollutant or traffic indicator and any outcome using ESCAPE-period estimates.
Associations in meta-analyses using main model 3 leaving out one cohort in turn (online supplements-8) or restricted to cohorts with 'contemporary exposure estimates': Asthma-E3N (2011), NSHD (2008) and SALIA (2006-2010) (online supplements-9) were all null except for associations between chronic cough and PM 2.5abs in analyses not including ECRHS, with OR, 95% CI 1.20 (1.01 to 1.44) per 10 −5 /m. Further adjustments in models 4 and 5 did not change the results substantially, although effect estimates were slightly smaller and the 95% CIs became wider (data not shown), which may in part relate to fewer participants.
Sensitive subgroups
In never-smokers, higher and uniformly positive effect estimates for all air pollutants and traffic indicators for all three outcomes were observed (table 3) . A statistically significant association was found between chronic phlegm and both PM 10 1.63) per 10 −5 /m, although with evidence of heterogeneity for the latter (P het =0.024). In the random-effects analysis, the PM 2.5abs result was not statistically significant: OR, 95% CI 1.58 (0.90 to 2.76) per 10 −5 /m. There were no statistically significant effect estimates observed in meta-analyses for asthmatics, females, participants aged 50+ years, participants without COPD and/or asthma or non-movers (results not shown).
Exposure-related sensitivity analyses
Sensitivity analyses for NO 2 and NO x excluding centres with LUR model validation R 2 statistics <0.6 gave similar null results for the main ESCAPE-period analyses (online supplements-10). The R 2 statistics were all >0.6 for PM estimates in our study areas.
Using back-extrapolated 'historic exposure estimates' to 1999-2002 (table 4), there were consistent but statistically nonsignificant elevated risks in all populations but not in neversmokers for all three outcomes with NO 2 and PM 10 . Using historic exposure estimates to the early 1990s in only two cohorts (table 5), statistically significant associations were found between NO 2 and both chronic bronchitis (OR: 1.10, 95% CI 1.00 to 1.22) and chronic cough (OR: 1.10, 95% CI 1.01 to 1.20) .
DISCUSSION
This is one of the largest studies to investigate the link between bronchitis symptoms and current air pollution exposures using five cohorts in nine European countries. Main analyses defined a priori did not show significant associations between the period prevalence of chronic bronchitis, cough or phlegm and any of six air pollutant metrics and two traffic indicators. Associations between the particulate measure of black carbon PM 2.5abs and chronic cough were statistically significant if leaving out a younger cohort (ECRHS) in analyses of all individuals and of never-smokers. In never-smokers, associations were in general larger and consistently positive, reaching statistical significance between phlegm and PM coarse (but not PM 2.5 ). The higher NO 2 exposures in the early 1990s were associated with chronic bronchitis and cough, but this analysis was only possible for two cohorts.
Findings in comparisons with previous studies
To our knowledge, this is one of the first epidemiological studies to report on long-term associations between the coarse fraction of ambient particles and cough and phlegm in adults. PM coarse has previously been found to be associated with respiratory hospital admissions 30 and to be more potent than fine PM in inducing inflammatory responses in in vitro and in vivo (mouse) studies. 31 32 We also observed significant associations between PM 10 and phlegm in never-smokers but not overall. As in this analysis, cross-sectional associations with chronic bronchitis and with phlegm were seen in never-smokers (but not in former and ) for chronic cough at the most recent assessment using the European Study of Cohorts for Air Pollution Effects (ESCAPE)-period exposures in the overall populations from all five cohorts. I-squared, variation in estimated effect attributable to heterogeneity; I-V, inverse-variance weighted fixed effects method; D-L, DerSimonian-Laird random effects method; ES, effect estimate; PM, particulate matter. current smokers) in the SAPALDIA study, 26 but no statistically significant associations were seen in SALIA (mainly nonsmokers) 23 while continuous measures of PM 10 were not associated with cough in older adults in France. 15 However, longitudinal analyses in both SALIA 22 and SAPALDIA 24 studies suggested declines in PM 10 are associated with declines in cough and chronic bronchitis symptoms; additionally, an analysis of Seventh Day Adventist non-smokers found associations between chronic cough and 15-year cumulative PM 10 exposures. 10 We saw no significant associations overall with PM 2.5 . This is consistent with previous cross-sectional epidemiological studies in adults in the USA 19 and a 2006 analysis of the ECRHS 25 cohort and with a longitudinal analysis in Melbourne 14 but not an analysis in non-smoking Seventh Day Adventists, which found associations between 20-year cumulative exposure to PM 2.5 and chronic bronchitis. 11 We did observe associations between chronic cough and PM 2.5abs , a measure of black carbon or soot, in some sensitivity analyses, but these were not consistent and may represent chance findings.
Lack of findings of significant associations with NO 2 , except for chronic cough and chronic bronchitis in SALIA and SAPALDIA in the 1990s when exposures were higher are partially consistent with previous studies. Significant associations were seen with cough, but not chronic bronchitis in a previous analysis of SALIA 23 ; with chronic bronchitis and with phlegm in women but not men in the ECRHS (cough was not considered) 25 ; with phlegm (but not cough) in women but not men in an older French cohort 15 ; and with chronic bronchitis and chronic phlegm in never-smokers in SAPALDIA. 26 Chronic bronchitis symptoms were not associated with low levels of cumulative NO 2 exposure in non-smoking Californians. 16 We are aware of only one adult study that has considered NO x and contrary to our null findings, exposures >19 vs 0-8 mg/m 3 in southern Sweden were associated with higher prevalences of chronic bronchitis. 17 We found no significant associations of traffic intensity with any chronic bronchitis symptoms, contrary to six previous studies using differing traffic intensity metrics based on traffic counts 17 23 and distance from road. 13 20 21 27 ORs using ESCAPE exposure estimates in individual cohorts were comparable with those from previously published analyses using cohort-specific air pollution estimates, allowing for differences in study design (see online supplements-11 for details).
Most 10-13 15-17 19-21 23 25-27 but not all 14 18 22 24 previous studies examining associations between air pollutant metrics and chronic bronchitis in adults have conducted cross-sectional analyses. We did not do a longitudinal analysis because symptoms come and go over time and they do not represent a stable chronic condition. Also, questionnaire-based reporting is most likely to capture symptoms experienced in the last few months, therefore reflecting cumulative prevalence of acute and subacute effects.
Strengths and weaknesses of the study
Strengths of this study are the use of five large existing cohorts in different parts of Europe, centrally defined harmonised †Estimates from random-effect meta-analysis as P het: <0.05. ‡Results were interpreted as per exposure unit, as shown in the parentheses. §P het: P-value for heterogeneity. ¶Binary variable, <5000 (reference group) vs >5000 vehs/day. **Binary variable, <500 000 (reference group) vs >500 000 vehs m/day. ECRHS, European Community Respiratory Health Survey; ESCAPE, European Study of Cohorts for Air Pollution Effects; NO x ; nitrogen oxides; NSHD, National Survey of Health and Development; PM, particulate matter; SALIA, Study on the influence of Air pollution on Lung function, Inflammation and Aging; SAPALDIA, Swiss cohort study on Air Pollution And Lung and heart Diseases in Adults.
variables for each cohort, standard assessment of exposures to eight traffic-related exposures individually assigned to home address and an identical prespecified statistical protocol. However, there were also several limitations. First, uncertainty in exposure estimates might have introduced non-systematic errors, reducing the power of the study to detect effects. However, analyses excluding models with spatial variation R 2 <0.6 did not substantially change the results (online supplements-10 and supplements-12) Second, exposure assessments for ESCAPE occurred years after questionnaire assessments in some cohorts. This was investigated using back-extrapolated exposure assessments aligned with questionnaire. Back-extrapolation assumes within-city spatial contrasts of air pollutants remain similar over long periods of time, for which there is some support from previous studies. 33 34 Third, harmonised information on confounders was limited. Fourth, there might be reporting bias, particularly reluctance to report phlegm in females. 35 Fifth, we conducted many statistical analyses and it is possible that observed associations were due to chance. Sixth, the cohorts were heterogeneous in both design and populations, which may have resulted in systematic differences between studies. To address this, we used harmonised variables, explored potential effect modifiers, used meta-analyses not pooled analyses and conducted leave-one-out sensitivity meta-analyses. Finally, we note that detecting effects in potentially susceptible subgroups, of relevance to environmental policy, may require much larger sample sizes than possible here.
In conclusion, although deleterious effects of ambient air pollution on a range of health outcomes including mortality are well documented, we did not find evidence for significant associations between current long-term average air pollution levels and symptoms of chronic bronchitis, cough or phlegm in >10 000 European adults. Our study findings, based on very large-scale harmonised population-based cohort studies using a priori specified analyses, contribute to strengthening the evidence-based studies for policy formulation. SALIA During the last decades, a lot of scientists, study nurses and laboratories were involved in conducting the study. As representatives for all these people, we would like to thank especially Reinhard Dolgner (MD) for organizing the baseline study and Barbara Schulten as study nurse for her help in organizing the follow-up study. We are most grateful for all the women from the Ruhr area and from Borken who participated in the study during decades. ECRHS was supported by the European Commission, as part of their Quality of Life programme.
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